Axa
SNV

Axa’s Synovus SNV Stock Holding History

Axa’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,300
Closed -$1.32M – 1213
2022
Q3 		$1.32M Sell
35,300
-800
-2% -$31.7K 0.01% 819
2022
Q2 		$1.3M Sell
36,100
-42,300
-54% -$1.75M ﹤0.01% 843
2022
Q1 		$3.84M Buy
78,400
+22,900
+41% +$1.16M 0.01% 719
2021
Q4 		$2.66M Sell
55,500
-1,100
-2% -$52.1K 0.01% 795
2021
Q3 		$2.48M Hold
56,600
– – 0.01% 817
2021
Q2 		$2.48M Buy
+56,600
New +$2.66M 0.01% 853
2019
Q4 		– Sell
-27,000
Closed -$966K – 1303
2019
Q3 		$966K Sell
27,000
-1,600
-6% -$57.4K ﹤0.01% 986
2019
Q2 		$1M Buy
28,600
+13,900
+95% +$483K ﹤0.01% 973
2019
Q1 		$505K Sell
14,700
-26,300
-64% -$965K ﹤0.01% 1103
2018
Q4 		$1.31M Hold
41,000
– – 0.01% 918
2018
Q3 		$1.88M Buy
+41,000
New +$2.06M 0.01% 890
2017
Q2 		– Sell
-38,600
Closed -$1.58M – 1296
2017
Q1 		$1.58M Buy
38,600
+1,200
+3% +$50.1K 0.01% 825
2016
Q4 		$1.54M Buy
+37,400
New +$1.38M 0.01% 816

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Axa's SNV Position: Q4 2022 in Review

Axa sold out of Synovus (SNV) in Q4 2022, closing a stake of 35,300 shares — an estimated $1.32M sold.

Axa first reported a position in SNV in Q4 2016 and held it in 13 quarters. The position peaked at $3.84M in Q1 2022. 419 funds tracked by Wall St. Rank hold SNV as of Q4 2022.

  • Axa reported no remaining Synovus position as of Q4 2022 after selling out during the quarter.
  • Axa sold 35,300 Synovus shares in Q4 2022, an estimated $1.32M.
  • Axa first reported a position in Synovus in Q4 2016 and held it in 13 quarters.
  • Axa's Synovus position peaked at $3.84M in Q1 2022.
  • 419 funds tracked by Wall St. Rank held Synovus as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.